Bayesian Capital Management’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,593
Closed -$228K 897
2024
Q3
$228K Buy
+5,593
New +$212K 0.03% 539
2024
Q2
Sell
-10,400
Closed -$329K 991
2024
Q1
$329K Buy
+10,400
New +$316K 0.03% 537
2022
Q3
Sell
-14,500
Closed -$409K 932
2022
Q2
$409K Buy
14,500
+108
+0.8% +$3.07K 0.08% 387
2022
Q1
$448K Sell
14,392
-1,200
-8% -$35.4K 0.07% 403
2021
Q4
$461K Sell
15,592
-15,996
-51% -$467K 0.15% 191
2021
Q3
$946K Buy
+31,588
New +$1.09M 0.27% 97
2020
Q4
Sell
-11,600
Closed -$347K 617
2020
Q3
$347K Buy
+11,600
New +$362K 0.08% 313

Other funds holding OHI

Bayesian Capital Management's OHI Position: Q4 2024 in Review

Bayesian Capital Management sold out of Omega Healthcare (OHI) in Q4 2024, closing a stake of 5,593 shares — an estimated $228K sold.

Bayesian Capital Management first reported a position in OHI in Q3 2020 and held it in 7 quarters. The position peaked at $946K in Q3 2021. 623 funds tracked by Wall St. Rank hold OHI as of Q4 2024.

  • Bayesian Capital Management reported no remaining Omega Healthcare position as of Q4 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 5,593 Omega Healthcare shares in Q4 2024, an estimated $228K.
  • Bayesian Capital Management first reported a position in Omega Healthcare in Q3 2020 and held it in 7 quarters.
  • Bayesian Capital Management's Omega Healthcare position peaked at $946K in Q3 2021.
  • 623 funds tracked by Wall St. Rank held Omega Healthcare as of Q4 2024.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.